OptimizeRx Corporation
OPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $92,127 | $71,522 | $62,450 | $61,293 |
| % Growth | 28.8% | 14.5% | 1.9% | – |
| Cost of Goods Sold | $32,749 | $28,622 | $23,483 | $25,654 |
| Gross Profit | $59,378 | $42,900 | $38,967 | $35,638 |
| % Margin | 64.5% | 60% | 62.4% | 58.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $61,266 | $58,020 | $49,236 | $27,514 |
| SG&A Expenses | $61,266 | $58,020 | $49,236 | $33,191 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $5,677 |
| Other Operating Expenses | $11,818 | $11,282 | $2,022 | $2,086 |
| Operating Expenses | $73,084 | $69,302 | $51,258 | $35,277 |
| Operating Income | -$13,706 | -$26,402 | -$12,291 | $361 |
| % Margin | -14.9% | -36.9% | -19.7% | 0.6% |
| Other Income/Exp. Net | -$5,679 | $1,238 | $852 | $17 |
| Pre-Tax Income | -$19,385 | -$25,164 | -$11,438 | $378 |
| Tax Expense | $725 | -$7,598 | $0 | $0 |
| Net Income | -$20,110 | -$17,566 | -$11,438 | $378 |
| % Margin | -21.8% | -24.6% | -18.3% | 0.6% |
| EPS | -1.1 | -1.03 | -0.64 | 0.022 |
| % Growth | -6.8% | -60.9% | -3,022.4% | – |
| EPS Diluted | -1.1 | -1.03 | -0.64 | 0.021 |
| Weighted Avg Shares Out | 18,293 | 17,125 | 17,784 | 17,228 |
| Weighted Avg Shares Out Dil | 18,293 | 17,125 | 17,784 | 17,690 |
| Supplemental Information | – | – | – | – |
| Interest Income | $329 | $2,192 | $852 | $17 |
| Interest Expense | $6,160 | $1,454 | $0 | $0 |
| Depreciation & Amortization | $4,329 | $2,402 | $2,022 | $1,965 |
| EBITDA | -$8,896 | -$21,308 | -$9,416 | $2,326 |
| % Margin | -9.7% | -29.8% | -15.1% | 3.8% |